Novo Nordisk A/S NVO
NYSE
Recommendation
Dividend Power Score
Day's Range
$40.64$41.80
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.16% | 13.20% | 16.85% | 11.16% | 18.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.16% | 13.20% | 16.85% | 11.16% | 18.66% |
| Cost of Revenue | 10.62% | 36.88% | 35.96% | 39.09% | 38.95% |
| Gross Profit | 11.28% | 8.77% | 13.39% | 6.23% | 15.03% |
| SG&A Expenses | -9.74% | -3.83% | 4.76% | 8.71% | 13.44% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 486.10% | 16.46% | 324.06% | -90.12% | 1,086.79% |
| Total Operating Expenses | 5.19% | 19.72% | 25.21% | 27.81% | 22.25% |
| Operating Income | 18.45% | 6.42% | 8.48% | -5.65% | 14.56% |
| Income Before Tax | 15.96% | 13.31% | 27.21% | 6.72% | 12.03% |
| Income Tax Expenses | 18.28% | 16.59% | 31.69% | 11.53% | 16.21% |
| Earnings from Continuing Operations | 15.33% | 12.43% | 26.02% | 5.48% | 10.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.33% | 12.43% | 26.02% | 5.48% | 10.95% |
| EBIT | 18.45% | 6.42% | 8.48% | -5.65% | 14.56% |
| EBITDA | 17.52% | 7.87% | 11.19% | -1.19% | 17.09% |
| EPS Basic | 15.59% | 12.57% | 26.13% | 5.71% | 11.29% |
| Normalized Basic EPS | 21.57% | 12.58% | 15.92% | -2.49% | 13.75% |
| EPS Diluted | 15.48% | 12.56% | 26.22% | 5.85% | 11.45% |
| Normalized Diluted EPS | 21.46% | 12.60% | 16.03% | -2.36% | 13.88% |
| Average Basic Shares Outstanding | -0.33% | -0.14% | -0.10% | -0.23% | -0.31% |
| Average Diluted Shares Outstanding | -0.22% | -0.16% | -0.20% | -0.35% | -0.44% |
| Dividend Per Share | 7.26% | 7.26% | 10.74% | 10.74% | 18.93% |
| Payout Ratio | -0.08% | 0.00% | -0.11% | 0.11% | 0.06% |